On Cancer

Search by keywords:

Show search filters

Explore by tags:

847 Blog posts found

In the Clinic

Imaging Technology Enables Doctors to Analyze Low-Grade Glioma

A noninvasive scanning technique is giving doctors the ability to assess brain tumors for genetic abnormalities without putting patients through the rigors of a brain biopsy.

Brain MRI images


MSK Study Examines Cancer-Care Outcomes among US Hospitals

A new study suggests that hospitals’ long-term survival outcomes for cancer patients can be sufficiently assessed without information on tumor stage.


Intraperitoneal Chemotherapy: A Better but Underused Option for Women with Advanced Ovarian Cancer

Gynecologic surgeon Dennis Chi explains how IP chemotherapy works – and why at MSK it’s part of the standard of care for women with stage 3 disease.

Illustration of chemotherapy being delivered to intraperitoneal space of human.


Immunotherapy Combination Nivolumab Plus Ipilimumab Receives FDA Approval for Metastatic Melanoma

Today, the US Food and Drug Administration approved the immunotherapy combination nivolumab plus ipilimumab, a regimen pioneered by MSK medical oncologist and cancer immunologist Jedd Wolchok.

A doctor wearing a white lab coat writes on a white board with a marker.


MSK’s Lorenz Studer Named a 2015 MacArthur Fellow

The awards are given annually to people in an array of fields in the arts and sciences.

A scientist pictured in his lab


Three Young Investigators Named Winners of 2015 Paul Marks Prize for Cancer Research

These early-career scientists are working on diverse areas of cancer biology including epigenetics, genetic changes that allow metastasis, and genomic integrity.

Paul Marks Prize medal

In the Clinic

Drugs Show New Promise in Fighting Advanced Renal Cell Carcinoma

Two treatments being studied at MSK are offering hope for advanced kidney cancer — and both have been granted breakthrough status by the US Food and Drug Administration.

A female nurse and a male doctor, both in white lab coats, talk with a male patient.

In the Lab

Researchers Discover How Gene Mutation Leads to Follicular Lymphoma

Research clarifies how abnormalities in a gene called KMT2D contribute to the development of follicular lymphoma, a common but incurable form of non-Hodgkin lymphoma.

A field of lymph nodes connected by multiple lymphatic vessels with one node in cross section showing the pathology of follicular lymphoma breaking through the node capsule.

In the Clinic

New Clinic Helps Lymphoma Survivors Stay Healthy

MSK’s Lymphoma Survivorship Clinic helps people manage the risk of late effects from treatment for lymphoma.

In the Clinic

Aggressive Lung Adenocarcinoma Subtype May Require New Treatment Strategy

Some early-stage lung adenocarcinoma patients have an aggressive subtype that often returns after surgery, even when tumors are small.

Microscopic image of lung cancer cells